XML 89 R74.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Equity (Schedule of Stock Awards) (Details) - Performance Stock Units - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Number of Shares      
Balance at beginning of the period (in shares) 162,381 149,961 119,727
Granted (in shares) 140,953 91,988 40,102
Dividend equivalents (in shares) 7,236 6,210 3,778
Forfeited (in shares) (3,245) (4,840) (1,053)
Vested (in shares) (100,046) (80,938) (12,593)
Balance at end of the period (in shares) 207,279 162,381 149,961
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Outstanding exercise price (in usd per share) $ 120.12 $ 104.01 $ 89.92
Granted (in usd per share) 108.42 110.83 143.54
Dividend equivalents (in usd per share) 117.20 103.29 134.82
Forfeited (in usd per share) 96.55 78.11 96.55
Vested (in usd per share) 101.11 82.40 95.03
Outstanding exercise price (in usd per share) $ 122.57 $ 120.12 $ 104.01